Prot #I4V-MC-JAHO(a): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very Severe Alopecia Areata

Project: Research project

Project Details

StatusActive
Effective start/end date7/12/1912/2/22

Funding

  • Lilly USA, LLC (Prot #I4V-MC-JAHO(a))